On the public citation graph

EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

0 signed · 101 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/emmm.201202343openalex-snapshot
ERBB4 confers metastatic capacity in Ewing sarcoma
inferredcites →https://doi.org/10.1002/iub.131openalex-snapshot
Lumican, a small leucine‐rich proteoglycan
inferredcites →https://doi.org/10.1006/exmp.2000.2303openalex-snapshot
Expression of Protein Tyrosine Phosphatases and Its Significance in Esophageal Cancer
inferredcites →https://doi.org/10.1016/j.canlet.2016.11.020openalex-snapshot
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
inferredcites →https://doi.org/10.1016/j.ccr.2009.04.009openalex-snapshot
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
inferredcites →https://doi.org/10.1016/j.ccr.2012.02.029openalex-snapshot
Targeting Nonclassical Oncogenes for Therapy in T-ALL
inferredcites →https://doi.org/10.1016/j.conb.2012.02.006openalex-snapshot
Human disorders of axon guidance
inferredcites →https://doi.org/10.1016/j.ejmech.2017.10.026openalex-snapshot
Design and synthesis of small molecule agonists of EphA2 receptor
inferredcites →https://doi.org/10.1016/j.suc.2016.05.012openalex-snapshot
Pediatric Sarcomas
inferredcites →https://doi.org/10.1021/acs.jproteome.5b00161openalex-snapshot
Chemical Proteomics Uncovers EPHA2 as a Mechanism of Acquired Resistance to Small Molecule EGFR Kinase Inhibition
inferredcites →https://doi.org/10.1021/acschembio.6b00709openalex-snapshot
Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs
inferredcites →https://doi.org/10.1038/bjc.2012.457openalex-snapshot
Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells
inferredcites →https://doi.org/10.1038/ncomms8679openalex-snapshot
Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
inferredcites →https://doi.org/10.1038/ng1180openalex-snapshot
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
inferredcites →https://doi.org/10.1038/nmeth.3252openalex-snapshot
Orchestrating high-throughput genomic analysis with Bioconductor
inferredcites →https://doi.org/10.1038/nrc3005openalex-snapshot
Novel roles for Slits and netrins: axon guidance cues as anticancer targets?
inferredcites →https://doi.org/10.1038/nrm.2015.16openalex-snapshot
Mechanisms of ephrin–Eph signalling in development, physiology and disease
inferredcites →https://doi.org/10.1038/onc.2008.101openalex-snapshot
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
inferredcites →https://doi.org/10.1038/onc.2010.525openalex-snapshot
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
inferredcites →https://doi.org/10.1038/onc.2013.272openalex-snapshot
Inflammatory chemokines and metastasis—tracing the accessory
inferredcites →https://doi.org/10.1073/pnas.0506580102openalex-snapshot
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
inferredcites →https://doi.org/10.1093/nar/29.9.e45openalex-snapshot
A new mathematical model for relative quantification in real-time RT-PCR
inferredcites →https://doi.org/10.1093/nar/gkv007openalex-snapshot
limma powers differential expression analyses for RNA-sequencing and microarray studies
inferredcites →https://doi.org/10.1093/nar/gng015openalex-snapshot
Summaries of Affymetrix GeneChip probe level data
inferredcites →https://doi.org/10.1111/febs.13342openalex-snapshot
Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases
inferredcites →https://doi.org/10.1111/j.2517-6161.1995.tb02031.xopenalex-snapshot
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
inferredcites →https://doi.org/10.1158/0008-5472.can-05-2468openalex-snapshot
Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia
inferredcites →https://doi.org/10.1158/0008-5472.can-06-3259openalex-snapshot
E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase
inferredcites →https://doi.org/10.1158/0008-5472.can-15-0717openalex-snapshot
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-16-1521openalex-snapshot
Eph Receptor Tyrosine Kinases in Tumor Immunity
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1585openalex-snapshot
Role of ADAMs in Cancer Formation and Progression
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-0603openalex-snapshot
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
inferredcites →https://doi.org/10.1158/1541-7786.mcr-10-0060openalex-snapshot
Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize
inferredcites →https://doi.org/10.1158/2159-8290.cd-14-0293openalex-snapshot
Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype
inferredcites →https://doi.org/10.1371/journal.pone.0071449openalex-snapshot
EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1
inferredcites →https://doi.org/10.18632/oncotarget.10872openalex-snapshot
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
inferredcites →https://doi.org/10.2174/1566524014666140128112827openalex-snapshot
Caveolin-1 in Cell Migration and Metastasis
inferredcites →https://doi.org/10.2202/1544-6115.1027openalex-snapshot
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
inferredcites →https://doi.org/10.2353/ajpath.2009.080473openalex-snapshot
Kinase-Dependent and -Independent Roles of EphA2 in the Regulation of Prostate Cancer Invasion and Metastasis
inferredcites →https://doi.org/10.3390/toxins8040122openalex-snapshot
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.5022615openalex-extracted
An Anti-Human Epha2 Monoclonal Antibody Ea2mab-7 Shows High Sensitivity for Flow Cytometry, Western Blot, and Immunohistochemical Analyses
inferred← citeshttps://doi.org/10.1002/1878-0261.13788openalex-snapshot
Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis
inferred← citeshttps://doi.org/10.1002/ctm2.70140openalex-snapshot
Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
inferred← citeshttps://doi.org/10.1007/978-1-0716-1020-6_16openalex-snapshot
Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts
inferred← citeshttps://doi.org/10.1007/s00011-026-02340-4openalex-snapshot
ADAM19: biological characteristics and implications in disease pathology and clinical applications
inferred← citeshttps://doi.org/10.1007/s00109-024-02431-xopenalex-snapshot
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.07.020openalex-snapshot
Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
inferred← citeshttps://doi.org/10.1016/j.bbagen.2023.130375openalex-snapshot
Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis
inferred← citeshttps://doi.org/10.1016/j.bbrep.2025.101998openalex-snapshot
Development of an anti-human EphA2 monoclonal antibody Ea2Mab-7 for multiple applications
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111863openalex-snapshot
Dual role of microRNA-1297 in the suppression and progression of human malignancies
inferred← citeshttps://doi.org/10.1016/j.bone.2020.115645openalex-snapshot
Crosstalk between skeletal and neural tissues is critical for skeletal health
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.12.040openalex-snapshot
LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
inferred← citeshttps://doi.org/10.1016/j.cellsig.2025.111750openalex-snapshot
TAK-901, a novel EPHA2 inhibitor as a therapeutic strategy against prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.173282openalex-snapshot
Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e19357openalex-snapshot
Prognostic value of GLCE and infiltrating immune cells in Ewing sarcoma
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.140138openalex-snapshot
Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer
inferred← citeshttps://doi.org/10.1016/j.jbo.2023.100482openalex-snapshot
Molecular and biologic biomarkers of Ewing sarcoma: A systematic review
inferred← citeshttps://doi.org/10.1016/j.jcyt.2021.12.010openalex-snapshot
CAR T targets and microenvironmental barriers of osteosarcoma
inferred← citeshttps://doi.org/10.1016/j.jot.2026.101235openalex-snapshot
Application of CAR-T cell therapy in orthopedics: From bone malignancies to non-malignant musculoskeletal disorders
inferred← citeshttps://doi.org/10.1016/j.omtn.2023.05.003openalex-snapshot
Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2024.108765openalex-snapshot
Signaling pathways and targeted therapies in Ewing sarcoma
inferred← citeshttps://doi.org/10.1016/j.phrs.2022.106609openalex-snapshot
BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway
inferred← citeshttps://doi.org/10.1038/s41388-024-03206-xopenalex-snapshot
EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation
inferred← citeshttps://doi.org/10.1038/s41417-020-00221-4openalex-snapshot
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours
inferred← citeshttps://doi.org/10.1038/s41419-021-03538-6openalex-snapshot
EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
inferred← citeshttps://doi.org/10.1038/s41419-024-06624-7openalex-snapshot
USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway
inferred← citeshttps://doi.org/10.1038/s41420-022-01124-zopenalex-snapshot
Exosomal circPABPC1 promotes colorectal cancer liver metastases by regulating HMGA2 in the nucleus and BMP4/ADAM19 in the cytoplasm
inferred← citeshttps://doi.org/10.1038/s41568-023-00634-xopenalex-snapshot
Eph receptors and ephrins in cancer progression
inferred← citeshttps://doi.org/10.1080/21645515.2026.2708435openalex-snapshot
The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions
inferred← citeshttps://doi.org/10.1097/cm9.0000000000003438openalex-snapshot
Innovative design concepts in tumor-targeting peptide-drug conjugates: Insights into emerging applications
inferred← citeshttps://doi.org/10.1097/md.0000000000040332openalex-snapshot
Comparative genomic analysis unveiling the mutational landscape associated with premalignant lesions and early-stage gastric cardia cancer
inferred← citeshttps://doi.org/10.1111/cas.70291openalex-snapshot
A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma
inferred← citeshttps://doi.org/10.1158/0008-5472.can-23-3334openalex-snapshot
Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors
inferred← citeshttps://doi.org/10.1177/1040638720985242openalex-snapshot
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines
inferred← citeshttps://doi.org/10.1186/s12943-022-01669-8openalex-snapshot
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
inferred← citeshttps://doi.org/10.1186/s12951-021-00781-zopenalex-snapshot
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
inferred← citeshttps://doi.org/10.1186/s12964-024-01811-7openalex-snapshot
Targeting the EphA2 pathway: could it be the way for bone sarcomas?
inferred← citeshttps://doi.org/10.1186/s12967-024-05900-6openalex-snapshot
Cellular crosstalk in the bone marrow niche
inferred← citeshttps://doi.org/10.1186/s13045-020-00944-9openalex-snapshot
Targeting EphA2 in cancer
inferred← citeshttps://doi.org/10.17179/excli2023-6760openalex-snapshot
Overall review of curative impact and barriers of CAR-T cells in osteosarcoma
inferred← citeshttps://doi.org/10.18632/aging.204852openalex-snapshot
The Eph/Ephrin system in primary bone tumor and bone cancer pain
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3938778/v1openalex-snapshot
Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancer
inferred← citeshttps://doi.org/10.2174/1386207325666220406112305openalex-snapshot
ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma
inferred← citeshttps://doi.org/10.21873/cgp.20447openalex-snapshot
Engineering of an EPHA2-Targeted Monobody for the Detection of Colorectal Cancer
inferred← citeshttps://doi.org/10.21873/invivo.12604openalex-snapshot
Establishment and Characterisation of Metastatic Extraskeletal Ewing Sarcoma Mouse Models
inferred← citeshttps://doi.org/10.3389/fcell.2020.00613openalex-snapshot
The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma
inferred← citeshttps://doi.org/10.3389/fimmu.2021.707211openalex-snapshot
A Novel Treatment for Ewing’s Sarcoma: Chimeric Antigen Receptor-T Cell Therapy
inferred← citeshttps://doi.org/10.3389/fonc.2021.629916openalex-snapshot
PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma via Modulation of EphA2 Expression
inferred← citeshttps://doi.org/10.3390/ani15172615openalex-snapshot
Super-Enhancer Drives THBS3 Expression to Regulate the Proliferation and Differentiation of Bovine Muscle Stem Cells
inferred← citeshttps://doi.org/10.3390/cancers13040700openalex-snapshot
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
inferred← citeshttps://doi.org/10.3390/cells10082075openalex-snapshot
Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
inferred← citeshttps://doi.org/10.3390/cells10112893openalex-snapshot
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma
inferred← citeshttps://doi.org/10.3390/cells13141201openalex-snapshot
The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells
inferred← citeshttps://doi.org/10.3390/ijms25073834openalex-snapshot
The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies
inferred← citeshttps://doi.org/10.3390/ijms27104326openalex-snapshot
Site-Specific Phosphoproteomic Profiling of CAV1 Reveals Co-Regulatory Kinase Networks in Cancer Signaling
inferred← citeshttps://doi.org/10.3390/jcm10081685openalex-snapshot
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
inferred← citeshttps://doi.org/10.3390/molecules23071596openalex-snapshot
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3
inferred← citeshttps://doi.org/10.3390/molecules25010119openalex-snapshot
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
inferred← citeshttps://doi.org/10.3892/ol.2022.13249openalex-snapshot
ALW‑II‑41‑27, an EphA2 inhibitor, inhibits proliferation, migration and invasion of cervical cancer cells via inhibition of the RhoA/ROCK pathway
inferred← citeshttps://doi.org/10.6084/m9.figshare.14183772openalex-snapshot
Additional file 1 of Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
inferred← citeshttps://doi.org/10.64898/2025.12.23.696151openalex-snapshot
Integrative multi-omics reveals PARP14 as a key IFNγ-regulated mediator of metastatic progression in Ewing sarcoma
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.